CLU and metabolic syndrome: The subgroup analysis of clusterin levels revealed that the presence of psoriasis (inflammation and oxidative stress) significantly elevated the level of clusterin; the level of clusterin was also higher in the no-MetS patients compared to the no-Mets controls.